Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin for chest indrawing pneumonia in children by CORPs
NCT02878031Phase 4Completed
- Sponsor
- Malaria Consortium
- Start
- Oct 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amoxicillin in pneumonia, sponsored by Malaria Consortium. Primary endpoints: Number of participants with clinical treatment failure at day 6 and Number of CHWs appropriately managing chest indrawing pneumonia at day 0. Started Oct 2016; status: completed.
02
Drugs
amoxicillin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT02878031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878031.